After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses

Every single patient with advanced pancreatic cancer who walked into Dr. Zev Wainberg’s office told him they would rather take an experimental medication than endure another round of chemotherapy. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Wainberg, co-director of UCLA Health’s GI Oncology Program, was leading a…

Read More